{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:05:58Z","timestamp":1785863158920,"version":"3.56.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s12325-013-0021-8","type":"journal-article","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T07:10:57Z","timestamp":1365232257000},"page":"420-429","source":"Crossref","is-referenced-by-count":23,"title":["Comparative Cross-sectional Analysis of the Effects of Topical Antiglaucoma Drugs on the Ocular Surface"],"prefix":"10.1007","volume":"30","author":[{"given":"Sangmoon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mee Kum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuk Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Ryang","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Myung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,4]]},"reference":[{"key":"21_CR1","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0161-6420(92)31774-9","volume":"99","author":"BE Klein","year":"1992","unstructured":"Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology. 1992;99:1499\u2013504.","journal-title":"Ophthalmology"},{"key":"21_CR2","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0161-6420(94)31090-6","volume":"101","author":"I Dielemans","year":"1994","unstructured":"Dielemans I, Vingerling JR, Wolfs RC, Hofman A, Grobbee DE, de Jong PT. The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology. 1994;101:1851\u20135.","journal-title":"Ophthalmology"},{"key":"21_CR3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/bjo.82.1.39","volume":"82","author":"C Baudouin","year":"1998","unstructured":"Baudouin C, de Lunardo C. Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers. Br J Ophthalmol. 1998;82:39\u201342.","journal-title":"Br J Ophthalmol."},{"key":"21_CR4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0939-6411(01)00246-6","volume":"53","author":"P Furrer","year":"2002","unstructured":"Furrer P, Mayer JM, Gurny R. Ocular tolerance of preservatives and alternatives. Eur J Pharm Biopharm. 2002;53:263\u201380.","journal-title":"Eur J Pharm Biopharm."},{"key":"21_CR5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","volume":"86","author":"PJ Pisella","year":"2002","unstructured":"Pisella PJ, Pouliquen P, Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol. 2002;86:418\u201323.","journal-title":"Br J Ophthalmol."},{"key":"21_CR6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/ICU.0b013e328089f1c8","volume":"18","author":"RW Yee","year":"2007","unstructured":"Yee RW. The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review. Curr Opin Ophthalmol. 2007;18:134\u20139.","journal-title":"Curr Opin Ophthalmol."},{"key":"21_CR7","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0161-6420(92)31847-0","volume":"99","author":"JM Herreras","year":"1992","unstructured":"Herreras JM, Pastor JC, Calonge M, Asensio VM. Ocular surface alteration after long-term treatment with an antiglaucomatous drug. Ophthalmology. 1992;99:1082\u20138.","journal-title":"Ophthalmology"},{"key":"21_CR8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bjo.59.11.667","volume":"59","author":"WS Wilson","year":"1975","unstructured":"Wilson WS, Duncan AJ, Jay JL. Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man. Br J Ophthalmol. 1975;59:667\u20139.","journal-title":"Br J Ophthalmol."},{"key":"21_CR9","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/ICO.0b013e3181c325b2","volume":"29","author":"RD Fechtner","year":"2010","unstructured":"Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea. 2010;29:618\u201321.","journal-title":"Cornea"},{"key":"21_CR10","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","volume":"17","author":"EW Leung","year":"2008","unstructured":"Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma. 2008;17:350\u20135.","journal-title":"J Glaucoma"},{"key":"21_CR11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/02713683.2011.562340","volume":"36","author":"WC Stewart","year":"2011","unstructured":"Stewart WC, Stewart JA, Nelson LA. Ocular surface disease in patients with ocular hypertension and glaucoma. Curr Eye Res. 2011;36:391\u20138.","journal-title":"Curr Eye Res."},{"key":"21_CR12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00061198-200312000-00007","volume":"12","author":"K Inoue","year":"2003","unstructured":"Inoue K, Okugawa K, Kato S, et al. Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy. J Glaucoma. 2003;12:480\u20135.","journal-title":"J Glaucoma"},{"key":"21_CR13","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.ico.0000220776.93852.d9","volume":"25","author":"JH Tsai","year":"2006","unstructured":"Tsai JH, Derby E, Holland EJ, et al. Incidence and prevalence of glaucoma in severe ocular surface disease. Cornea. 2006;25:530\u20132.","journal-title":"Cornea"},{"key":"21_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1542-0124(12)70120-9","volume":"3","author":"PA Asbell","year":"2005","unstructured":"Asbell PA, Potapova N. Effects of topical antiglaucoma medications on the ocular surface. Ocul Surf. 2005;3:27\u201340.","journal-title":"Ocul Surf."},{"key":"21_CR15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/jop.2008.0098","volume":"25","author":"SP Epstein","year":"2009","unstructured":"Epstein SP, Ahdoot M, Marcus E, Asbell PA. Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells. J Ocul Pharmacol Ther. 2009;25:113\u20139.","journal-title":"J Ocul Pharmacol Ther."},{"key":"21_CR16","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s00417-010-1397-7","volume":"248","author":"A Shedden","year":"2010","unstructured":"Shedden A, Adamsons IA, Getson AJ, et al. Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide\/timolol fixed combination (COSOPTTM) in patients with elevated intraocular pressure in a randomized clinical trial. Graefes Arch Clin Exp Ophthalmol. 2010;248:1757\u201364.","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"21_CR17","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","volume":"102","author":"A Alm","year":"1995","unstructured":"Alm A, Stjernschantz J. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group. Ophthalmology. 1995;102:1743\u201352.","journal-title":"Ophthalmology"},{"key":"21_CR18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","volume":"103","author":"CB Camras","year":"1996","unstructured":"Camras CB. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group. Ophthalmology. 1996;103:138\u201347.","journal-title":"Ophthalmology"},{"key":"21_CR19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(96)30750-1","volume":"103","author":"P Watson","year":"1996","unstructured":"Watson P, Stjernschantz J. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group. Ophthalmology. 1996;103:126\u201337.","journal-title":"Ophthalmology"},{"key":"21_CR20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1442-9071.2000.00237.x","volume":"28","author":"MK Arici","year":"2000","unstructured":"Arici MK, Arici DS, Topalkara A, Guler C. Adverse effects of topical antiglaucoma drugs on the ocular surface. Clin Experiment Ophthalmol. 2000;28:113\u20137.","journal-title":"Clin Experiment Ophthalmol."},{"key":"21_CR21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1034\/j.1600-0420.2000.078001037.x","volume":"78","author":"J Thygesen","year":"2000","unstructured":"Thygesen J, Aaen K, Theodorsen F, Kessing SV, Prause JU. Short-term effect of latanoprost and timolol eye drops on tear fluid and the ocular surface in patients with primary openangle glaucoma and ocular hypertension. Acta Ophthalmol Scand. 2000;78:37\u201344.","journal-title":"Acta Ophthalmol Scand."},{"key":"21_CR22","first-page":"149","volume":"105","author":"M Ohtsuki","year":"2001","unstructured":"Ohtsuki M, Yokoi N, Mori K, et al. Adverse effects of beta-blocker eye drops on the ocular surface. Nihon Ganka Gakkai Zasshi. 2001;105:149\u201354.","journal-title":"Nihon Ganka Gakkai Zasshi"},{"key":"21_CR23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/bjo.74.7.409","volume":"74","author":"SS Weissman","year":"1990","unstructured":"Weissman SS, Asbell PA. Effects of topical timolol (0.5%) and betaxolol (0.5%) on corneal sensitivity. Br J Ophthalmol. 1990;74:409\u201312.","journal-title":"Br J Ophthalmol."},{"key":"21_CR24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jop.1990.6.85","volume":"6","author":"R Vogel","year":"1990","unstructured":"Vogel R, Clineschmidt CM, Hoeh H, Kulaga SF, Tipping RW. The effect of timolol, betaxolol, and placebo on corneal sensitivity in healthy volunteers. J Ocul Pharmacol. 1990;6:85\u201390.","journal-title":"J Ocul Pharmacol."},{"key":"21_CR25","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0002-9394(01)01143-6","volume":"132","author":"ML Marques Pereira","year":"2001","unstructured":"Marques Pereira ML, Katz LJ. Choroidal detachment after the use of topical latanoprost. Am J Ophthalmol. 2001;132:928\u20139.","journal-title":"Am J Ophthalmol."},{"key":"21_CR26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0002-9394(01)01411-8","volume":"133","author":"M Wand","year":"2002","unstructured":"Wand M, Gaudio AR. Cystoid macular edema associated with ocular hypotensive lipids. Am J Ophthalmol. 2002;133:403\u20135.","journal-title":"Am J Ophthalmol."},{"key":"21_CR27","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archopht.1997.01100160307007","volume":"115","author":"LW Herndon","year":"1997","unstructured":"Herndon LW, Choudhri SA, Cox T, Damji KF, Shields MB, Allingham RR. Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes. Arch Ophthalmol. 1997;115:1137\u201341.","journal-title":"Arch Ophthalmol."},{"key":"21_CR28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0002-9394(98)00438-3","volume":"127","author":"A Konowal","year":"1999","unstructured":"Konowal A, Morrison JC, Brown SV, et al. Irreversible corneal decompensation in patients treated with topical dorzolamide. Am J Ophthalmol. 1999;127:403\u20136.","journal-title":"Am J Ophthalmol."},{"key":"21_CR29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/jop.2010.0133","volume":"27","author":"C Valente","year":"2011","unstructured":"Valente C, Lester M, Corsi E, Rolando M. Symptoms and signs of tear film dysfunction in glaucomatous patients. J Ocul Pharmacol Ther. 2011;27:281\u20135.","journal-title":"J Ocul Pharmacol Ther."},{"key":"21_CR30","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ajo.2010.10.032","volume":"151","author":"MA Lemp","year":"2011","unstructured":"Lemp MA, Bron AJ, Baudouin C, et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol. 2011;151:792\u20138, e1.","journal-title":"Am J Ophthalmol."},{"key":"21_CR31","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/ICO.0b013e318242fd60","volume":"31","author":"BD Sullivan","year":"2012","unstructured":"Sullivan BD, Crews LA, Sonmez B, et al. Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management. Cornea. 2012;31:1000\u20138.","journal-title":"Cornea"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-013-0021-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-013-0021-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-013-0021-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T07:56:03Z","timestamp":1559462163000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-013-0021-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["21"],"URL":"https:\/\/doi.org\/10.1007\/s12325-013-0021-8","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}